DxGen is a global Point-Of-Care(POC) diagnostics company and devoted to developing multi-marker for people with diabetes and coronavirus.

We provide total solution and offers tools and services to help developing POC products from concept through commercialization. Healthcare professionals will have reliable test results in minutes with the lab quality precision and accuracy while operating cost effectively.

Our goal is to help make clinical decisions in the care and treatment of patients at the time and place.

We are committed to applying leading-edge technology for high-quality products.

We endeavor to be a global leader and deliver technical innovation continuously.